Extracellular vesicles could be personalised drug delivery vehicles
Researchers developed an approach and platform to create large amounts of fillable and targeted nanovesicles to deliver drugs to tumours in mice...
List view / Grid view
Researchers developed an approach and platform to create large amounts of fillable and targeted nanovesicles to deliver drugs to tumours in mice...
The new SUSHI technique allows the tiny space full of liquid surrounding brain cells to be labelled...
An international research consortium has identified a novel gene involved in breast cancer
Researchers have showed how a common virus hijacks a host cell’s protein to help assemble new viruses before they are released.
A study has pinpointed a molecule that links autophagy and apoptosis, namely a transcription factor called FOXO3a.
Researchers have uncovered a way to treat aggressive tumours through manipulation of the connective tissue cells of the tumour.
Scientists have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology...
Researchers identify the overabundance of a specific protein in the brain of people who have MS...
A discovery sheds light on how cancerous cells differ from healthy ones and could lead to the development of new strategies for therapeutic intervention for difficult-to-treat cancers...
Study provides a roadmap for using CRISPR to investigate neurological disorders...
Protein pathways that are closely linked to changes in both triglyceride and haemoglobin A1c levels in diabetic patients have been identified...
Researchers have found that patients who receive cardiac PET imaging instead of SPECT experienced a significant increase in the detection of severe obstructive coronary artery disease...
Looking forward to some of the Asthma & COPD 2018 conference highlights...
In its 10th year, the Adaptive Designs in Clinical Trials conference returns to central London in April 2018...
Scientists have discovered a way to rein in an overactive protein that drives some aggressive leukaemias...